Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - NetReceivables - Other
Ratios

Cardiff Oncology (CRDF) Leases (2019 - 2025)

Cardiff Oncology's Leases history spans 7 years, with the latest figure at $629000.0 for Q4 2025.

  • For Q4 2025, Leases fell 46.19% year-over-year to $629000.0; the TTM value through Dec 2025 reached $629000.0, down 46.19%, while the annual FY2025 figure was $629000.0, 46.19% down from the prior year.
  • Leases for Q4 2025 was $629000.0 at Cardiff Oncology, down from $764000.0 in the prior quarter.
  • Across five years, Leases topped out at $3.0 million in Q3 2021 and bottomed at $178000.0 in Q2 2021.
  • The 5-year median for Leases is $1.6 million (2023), against an average of $1.6 million.
  • The largest annual shift saw Leases tumbled 64.53% in 2021 before it skyrocketed 1317.98% in 2022.
  • A 5-year view of Leases shows it stood at $2.8 million in 2021, then dropped by 19.49% to $2.3 million in 2022, then decreased by 24.12% to $1.7 million in 2023, then crashed by 31.56% to $1.2 million in 2024, then tumbled by 46.19% to $629000.0 in 2025.
  • Per Business Quant, the three most recent readings for CRDF's Leases are $629000.0 (Q4 2025), $764000.0 (Q3 2025), and $899000.0 (Q2 2025).